Recent Company News

• 03:06 AM ET Dec 01, 2025
  

  Fresenius launches denosumab biosimilars, Conexxence and Bomyntra, in Europe (€47.18, -0.15)

• 12:28 PM ET Nov 05, 2025
  

  Transcript Intelligence: Fresenius Q3 Earnings Themes (€48.05, 0.00)

• 12:28 PM ET Nov 05, 2025
  

  Transcript Intelligence: Fresenius Q3 Earnings Guidance (€48.05, 0.00)

• 12:27 PM ET Nov 05, 2025
  

  Transcript Intelligence: Fresenius Q3 Earnings Q&A (€48.05, 0.00)

• 09:00 AM ET Nov 04, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 02:57 AM ET Nov 05, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:06 AM ET Nov 05, 2025
  

  StreetAccount Metrics Recap - Fresenius Q3 Earnings (€48.52, 0.00)

• 01:02 AM ET Nov 05, 2025
  

  Fresenius reports Q3 EPS €0.62 ex-items; raises FY guidance (€48.52, 0.00)

• 05:10 PM ET Nov 04, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market